Real estate investment trust Alexandria Real Estate Equities Inc. has sold a 70% stake in part of a biotech campus in Seattle, a deal that values the office and laboratory properties at $450 million.
Real estate investment trust Alexandria Real Estate Equities Inc. has sold a 70% stake in part of a biotech campus in Seattle, a deal that values the office and laboratory properties at $450 million.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
1201 Eastlake Ave, Seattle, WA